May 12, 2026 7:05am EDT Unicycive Therapeutics Announces First Quarter 2026 Financial Results and Provides Business Update
Apr 09, 2026 7:05am EDT Unicycive Therapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference
Mar 30, 2026 7:05am EDT Unicycive Therapeutics Announces Full Year 2025 Financial Results and Provides Business Update
Feb 04, 2026 7:05am EST Unicycive Therapeutics to Participate in a Fireside Chat at Guggenheim’s Emerging Outlook: Biotech Summit
Jan 29, 2026 9:15am EST UPDATE - Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate (OLC) New Drug Application (NDA) Resubmission
Jan 29, 2026 7:05am EST Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate (OLC) New Drug Application (NDA) Resubmission
Dec 29, 2025 7:05am EST Unicycive Therapeutics Announces Resubmission of New Drug Application (NDA) for Oxylanthanum Carbonate (OLC)
Nov 25, 2025 7:05am EST Unicycive Therapeutics to Participate in Upcoming Investor Events in December
Nov 12, 2025 7:05am EST Unicycive Therapeutics Announces Third Quarter 2025 Financial Results and Provides Business Update
Nov 03, 2025 7:05am EST Unicycive Therapeutics to Participate in a Fireside Chat at the Guggenheim 2nd Annual Healthcare Innovation Conference
